Honest about what we measure — and what we don't.
Trust matters more than cleverness. Melloba is designed to describe everyday interactions responsibly, and to be transparent about the limits of that description.
Descriptive, not diagnostic
Melloba describes what happens in an interaction. It does not diagnose conditions, assess whether a child is developing "correctly", or label a child as ahead or behind. There are no "good" or "bad" scores for your child.
No medical diagnosis
Melloba is not a medical device and is not a substitute for professional advice. Nothing in the app should be read as a clinical assessment. If you have concerns about your child's development or health, please speak with a qualified professional.
No risk prediction
Melloba does not predict future outcomes or risk. It reflects patterns in the interactions you record — nothing more. We deliberately avoid predictive claims because they are easy to misread and hard to justify responsibly.
Every measurement has limits
A short recording is a small window. Audio quality, context, mood, and countless everyday factors all shape what is captured. Melloba states these limitations alongside its reports so you can weigh them, rather than presenting numbers as certainties.
How AI is used — and where it stops
Melloba uses AI to help describe behaviour from a transcript of the interaction. Everything downstream of that description — the measurements, the scoring, the reports — is deterministic and rule-based. The same input produces the same output, which makes results consistent and reviewable rather than a black box.
Our guardrails, in short
- Describes interactions; does not diagnose or predict
- AI describes behaviour; measurement and scoring are deterministic
- Limitations are stated openly with every report
- No "good/bad" framing and no child leaderboards or gamification
Melloba's measurement approach is grounded in the product's internal scientific validation framework. Specific claims and references are maintained with the product and are subject to ongoing review.